1 pahu (10 Vials)
| Loaʻa: | |
|---|---|
| Ka nui: | |
▎ He aha ka MOTs-C?
ʻO MOTs-C kahi peptide i loaʻa mai i ka mitochondrial i hoʻopili ʻia e ka ʻāpana 12S rRNA o ka DNA mitochondrial, nona ka 16 amino acids. Ma ke ʻano he hōʻailona retrograde mitochondrial, hiki i ka MOTs-C ke unuhi i ka nucleus cell ma lalo o nā kūlana e like me ke koʻikoʻi metabolic, e hoʻoponopono ana i ka hōʻike ʻana o ke ʻano o nā genes e pili ana me ka metabolic dysfunction. Hoʻolaha nui ʻia ia i loko o nā ʻiʻo kino like ʻole e like me nā puʻupaʻa, ka ʻiʻo puʻuwai, a me ka ʻiʻo iwi, a aia pū kekahi i loko o ka plasma. Hiki iā ia ke hele i ka pale koko-lolo a hoʻoponopono i ke koena o ka ikehu cellular, glucose, a me ka maʻi maʻi lipid ma o ka hoʻāla ʻana i ke ala AMPK, e pāʻani ana i kahi kuleana koʻikoʻi i ka mālama ʻana i ke olakino metabolic. Loaʻa iā ia nā hopena i ka hoʻomaikaʻi ʻana i ka insulin resistance, ka pale ʻana i ka maʻi diabetes type 2, ka hoʻoponopono ʻana i ka maʻi diabetes momona, a me ka pale ʻana i ke olakino cardiovascular a me neural.
▎ MOTs-CSstruction
Puna: PubChem |
Kaʻina: MRWQEMGYIFYPRKLR Ke Kumu Molekala: C101H152N28O22S2 Kaumaha Molekala: 2174.6g/mol Helu CAS: 1627580-64-6 PubChem CID: 146675088 Nā huaʻōlelo like: UNII-A5CV6JFB78 |
▎ MOTs-C Research
He aha ke kumu noiʻi o MOTs-C?
ʻO ke kumu noiʻi o MOTs-C i hoʻokumu ʻia mai nā noiʻi i ke kuleana o ka DNA mitochondrial i ke olakino metabolic a me ka ʻelemakule. I ka hohonu o ka hoʻomaopopo ʻana i ka hana mitochondrial, ua ʻike ʻia ʻaʻole ʻo ka mitochondria wale nō ke kikowaena o ka maʻi diabetes akā komo pū kekahi i ke kamaʻilio kelepona a me ka transduction hōʻailona. Ma ka hoʻolalelale ʻana i ke ala AMPK, ua komo lākou i ka maʻi maʻi glucose a me ka lipid, pili loa i nā maʻi metabolic e like me ka maʻi diabetes a me ka momona, a paʻa i ka ʻōlelo hoʻohiki ma ke ʻano he mau pahuhopu therapeutic hou no kēia mau kūlana. Hāʻawi ʻia i ka hui ʻana ma waena o ka hana mitochondrial a me nā maʻi like ʻole, ua hoʻohana pū ʻia ʻo MOT-C i nā kūlana e like me ka hepatitis B mau a me ka maʻi maʻi ovarian. Hōʻike ka noiʻi he mea nui paha ia i nā kaʻina hana maʻi viral. Hoʻoikaika ka hoʻoikaika kino i ka synthesis a me ka hōʻike ʻana o MOTs-C i loko o ke kino o ke kanaka, ma laila e hoʻomaikaʻi ai i ka maʻi diabetes, ka hana kino, a me ka hana holoʻokoʻa o ke kino, e hāʻawi ana i nā hōʻike no nā hoʻolālā anti-aging e pili ana i ka hoʻoikaika kino a me ka hoʻonui ʻana i ke ʻano o ka noiʻi MOTs-C.
He aha ka hana o ka MOTs-C?
Hoʻolaʻa ʻia o ke ala hōʻailona AICAR-AMPK:
Hoʻohana mua ʻo MOTs-C i kāna mau hana physiological ma ka hoʻāla ʻana i ke ala hōʻailona AICAR-AMPK. Hoʻopilikia ia i ka pōʻai folate-methionine i loko o nā pūnaewele, a laila hoʻāla i ke ala hōʻailona AICAR-AMPK. No ka laʻana, i nā kaʻina hana physiological e like me ka hoʻomaikaʻi ʻana i ka pale ʻana o ka insulin a me ka pale ʻana i ka momona, ʻo ka hoʻāla ʻana o kēia alahele he mea nui. Ma ka ho'ālaʻana i kēia alahele, hiki i ka MOTs-C ke hoʻoponopono i ka maʻi diabetes ikehu, hoʻonui i ka laweʻana o ka pūnaewele a me ka hoʻohanaʻana i ka glucose, a laila e hoʻoponopono ai i ka homeostasis metabolic systemic [1,2].
Nā pilina me nā ala hōʻailona kikoʻī a me nā genes:
I loko o nā puʻupuʻu muscle, hui pū ʻo MOTs-C me ka transduction hōʻailona a me ka transcription activator 3 (STAT3) ma o kāna YIFY domain's putative Src-homologous 2 (SH2) motif hoʻopaʻa ʻia, e hōʻemi ana i ka hana transcriptional a STAT3 a me ka hoʻonui ʻana i ka hoʻokumu ʻana o ka myotube. I ka radiation pneumonitis, MOTs-C e hoʻohaʻahaʻa i ka pōʻino o ka pūpū, ka mumū, a me ke koʻikoʻi oxidative ma o ka hoʻonui ʻana i ka helu nuklea E2-related factor (Nrf2) a me ka hoʻolaha ʻana i kāna translocation nuklea, no laila e pale ai i ka hana mitochondrial. Hoʻohui ʻia, hana ʻo MOTs-C i nā hana physiological like ʻole ma o ka hoʻoponopono ʻana i ka hōʻike ʻana o nā genes e like me GLUT4, STAT3, a me IL-10 [3].
Hoʻoponopono i nā ala metabolic:
Hoʻokomo ʻo MOTs-C i ka hoʻoponopono ʻana i nā kaʻina hana metabolic koʻikoʻi, me ka maʻi diabetes glucose, ka maʻi maʻi lipid, a me ka maʻi diabetes iwi, ma o nā ʻano autocrine a me paracrine. I ka maʻi maʻi glucose, hoʻomaikaʻi ia i ka pale ʻana o ka insulin a hoʻoponopono i nā pae glucose koko; i ka maʻi maʻi lipid, hoʻonui ia i ka thermogenesis momona brown, paipai i ka momona keʻokeʻo browning, a pale i ka momona a me nā maʻi maʻi maʻi lipid; i ka maʻi diabetes iwi, hoʻoikaika ia i ka hoʻonui ʻana o ka osteoblast, ka ʻokoʻa, a me ka mineralization, ke kāohi i ka hanauna osteoclast, a hoʻoponopono i ka maʻi diabetes a me ka hoʻoponopono hou ʻana o ka iwi [4,5].

Kiʻi 1 Mechanism a me ka hana o MOTs-C [6].
He aha nā hana a me nā noi o MOTs-C?
Nā hana o MOTs-C
Nā hopena hoʻoponopono i ka maʻi diabetes:
Hiki i nā MOT-C ke hoʻomaikaʻi i ka glucose a me ka maʻi maʻi lipid i ke kino. I ka maʻi maʻi glucose, hoʻemi ia i ka pale ʻana o ka insulin, kōkua i ka pale ʻana i ka maʻi maʻi type 2, a hoʻonui i ka lawe ʻana i nā kelepona a me ka hoʻohana pono ʻana o ka glucose. I ka maʻi maʻi lipid, hoʻonui ia i ka thermogenesis momona brown, hoʻoikaika i ka browning o ka momona keʻokeʻo, a laila hoʻoponopono i ka maʻi diabetes lipid, pale i ka momona, a me nā maʻi metabolic lipid pili. Hoʻemi pū ia i ka maʻi o ka maʻi momona momona ʻole a hoʻoponopono i ka maʻi maʻi hepatic lipid [2].
Nā hopena i ka hana kelepona:
Hoʻoikaika ia i ka hana mitochondrial a pale i nā pūnaewele mai ka pōʻino. No ka laʻana, i ka maʻi maʻi maʻi radiation, hoʻemi ia i ka pōʻino mitochondrial i loko o nā pūpū epithelial māmā, hoʻemi i ka apoptosis cell, a mālama i ka hana maʻamau. I loko o nā pancreatic cell, MOTs-C ka hopena i ka huna a me ka hōʻike ʻana o ka insulin a me ka glucagon, ka hoʻoponopono ʻana i ka physiology cell pancreatic, a pili pū kekahi i ka viability cellular a me ka apoptosis [4,5].
Nā hopena i nā ʻiʻo a me nā iwi:
I loko o nā ʻiʻo, hoʻoikaika ʻo MOTs-C i ka hoʻokaʻawale ʻana o nā ʻiʻo progenitor cell, hoʻonui i ka hoʻokumu ʻana o ka myotube, a pale i nā ʻiʻo ʻiʻo mai ka interleukin-6 (IL-6) -induced pōʻino, hiki ke pale i ka atrophy muscle. Ma ka ʻōlelo o nā iwi, hoʻoikaika ia i ka hoʻonui ʻana, ka ʻokoʻa, a me ka mineralization o nā osteoblasts, ke kāohi nei i ka hoʻokumu ʻana o ka osteoclast, mālama i ka pale metabolic iwi, a kōkua i ka lohi ʻana i ka osteoporosis [1,5].
Nā hopena anti-inflammatory a me immunomodulatory:
Hoʻemi ʻo MOTs-C i nā pane inflammatory maʻamau a hoʻoponopono i ka hana immune. I loko o nā hiʻohiʻona ʻehaʻeha, MOTs-C e hoʻohaʻahaʻa i ka hypersensitivity ʻeha, e hoʻemi i ka hoʻokuʻu ʻana o nā mea inflammatory, a ke kāohi i ka hoʻoulu ʻana o nā cell glial a me nā neurons, e hōʻike ana i nā hopena anti-inflammatory a me ka hōʻeha ʻeha [3].
Nā noi o MOTs-C
Nā hopena i nā maʻi metabolic:
ʻO nā hopena hoʻoponopono o MOTs-C i ka glucose a me ka maʻi maʻi lipid e lilo ia i mea hoʻomaʻamaʻa hou no nā maʻi metabolic e like me ka maʻi diabetes type 2, ka momona, a me ka maʻi momona momona ʻole [2].
Kāohi a mālama ʻana i nā maʻi musculoskeletal:
Hiki ke hoʻohana ʻia kona hopena maikaʻi i nā ʻiʻo a me nā iwi e pale a mālama i nā maʻi pili i ka atrophy a me nā maʻi iwi e like me ka osteoporosis. No nā poʻe maʻi me ka ʻiʻo atrophy, hiki iā ia ke hoʻomaikaʻi i ka hana o ka ʻiʻo ma o ka hoʻolaha ʻana i ka ʻokoʻa o ka ʻiʻo a me ka pale ʻana i ka apoptosis cell muscle; No nā poʻe maʻi me ka osteoporosis, hiki iā ia ke hoʻoponopono i ka pale metabolic iwi, hoʻonui i ka iwi iwi, a pale a mālama i ka osteoporosis [1,5].
Ka pale ʻana i ka pōʻino o ka radiation:
Ma nā haʻawina e pili ana i ka pneumonitis radiation, ua hōʻike ʻo MOTs-C i nā hopena pale i ka hōʻino ʻana i ka maʻi māmā. Hiki ke hoʻohana ʻia i ka wā radiotherapy e pale i nā ʻiʻo maʻamau, e hōʻemi i ka pōʻino o ka ʻiʻo i hoʻoiho ʻia e ka radiation, a hoʻonui i ka pono o ka radiotherapy [2].
Ka mālama ʻana i nā maʻi ʻeha:
Ma muli o kāna mau hopena anti-inflammatory, hiki ke hoʻohana ʻia ka MOTs-C e mālama i nā maʻi ʻeha e like me ka ʻeha ʻeha, e hāʻawi ana i nā kuhikuhi hou no ka mālama ʻana i ia mau kūlana [3].
Ka hopena
Ma keʻano he peptide i loaʻa i ka mitochondrial, hiki i ka MOTs-C ke ho'āla i nā ala hōʻailona e hoʻoponopono i ka glucose a me ka maʻi diabetes lipid, hoʻonui i ka insulin resistance, a ho'ēmi i ka pilikia o nā maʻi maʻi; hiki iā ia ke mālama i ka hana ʻiʻo a me ka iwi, pale i ka atrophy muscle a me ka osteoporosis; a loaʻa iā ia nā hana anti-inflammatory a me nā cell-protection, e pāʻani ana i ka pale ʻana i ka pōʻino o ka radiation a me ka mālama ʻana i nā maʻi ʻeha.
No ka mea kakau
ʻO nā mea i ʻōlelo ʻia ma luna nei ua noiʻi ʻia, hoʻoponopono ʻia a hōʻuluʻulu ʻia e Cocer Peptides.
Mea kākau moʻolelo ʻepekema
Ua pili ʻo Wan, Yanmin me nā hui hanohano like ʻole, me nā halemai, nā kikowaena noiʻi, nā kulanui, a me nā ʻoihana e like me Linping Hosp Integrated Tradit Chinese & Western M, Shanghai Sci Tech Inno Ctr Infect & Immun, Yunnan Agricultural University, etc. Ma ke kahua o Immunology Science & Technology, ʻimi ʻo ia i nā hana a me nā noi o ka ʻōnaehana pale. ʻO kāna noiʻi Virology e pili ana i nā hiʻohiʻona viral, ka lawe ʻana, a me ka pale ʻana. I loko o ke kahua o Materials Science Chemistry, ua kūpaʻa ʻo ia i ka hoʻomohala ʻana i nā waiwai waiwai a me ka hoʻohana hou ʻana o ke kemika, e hoʻolilo iā ia i mea kaulana me nā holomua noiʻi koʻikoʻi ma nā kula kula pili. Ua helu ʻia ʻo Wan, Yanmin ma ka ʻōlelo kuhikuhi [6].
▎ Nā ʻōlelo pili
[1] García-Benlloch S, Revert-Ros F, Blesa JR, et al. Hoʻoikaika ka MOTs-C i ka hoʻokaʻawale ʻana o ka ʻiʻo i loko o ka vitro [J]. Peptides, 2022,155:170840.DOI:10.1016/j.peptides.2022.170840.
[2] Zhang Y, Huang J, Zhang Y, et al. ʻO ka Mitochondrial-Derived Peptide MOTs-C Hoʻopau i ka Radiation Pneumonitis ma o ka Nrf2-Dependent Mechanism[J]. Nā Antioxidants, 2024,13.
[3] Wang Z, Yang L, Xu L, a me al. ʻO ka mīkini kikowaena a me ka peripheral o MOTs-C e hōʻemi i ka hypersensitivity ʻeha i kahi ʻano ʻiole o ka ʻeha ʻeha [J]. ʻImi Neurological, 2024,46(2):165-177.DOI:10.1080/01616412.2023.2258584.
[4] Bień J, Pruszyńska-Oszmałek E, Kołodziejski P, et al. Hoʻoponopono ʻo MOTs-C i ka alpha pancreatic a me ka hana beta cell in vitro [J]. Histochemistry and Cell Biology, 2024,161(6):449-460.DOI:10.1007/s00418-024-02274-0.
[5] Yi X, Hu G, Yang Y, et al. Ke kuleana o MOTs-C i ka hoʻoponopono ʻana i ka maʻi diabetes iwi [J]. Frontiers in Physiology, 2023,14:1149120.DOI:10.3389/fphys.2023.1149120.
[6] Wan W, Zhang L, Lin Y, a me al. ʻO ka peptide i loaʻa i ka mitochondria MOTs-C: nā hopena a me nā hana e pili ana i ke kaumaha, ka maʻi diabetes a me ka ʻelemakule [J]. Journal of Translational Medicine, 2023,21(1):36.DOI:10.1186/s12967-023-03885-2.
ʻO nā ʻatikala a me nā ʻike huahana i hāʻawi ʻia ma kēia pūnaewele pūnaewele wale nō no ka hoʻolaha ʻana i ka ʻike a me nā kumu hoʻonaʻauao.
ʻO nā huahana i hāʻawi ʻia ma kēia pūnaewele i manaʻo wale ʻia no ka noiʻi in vitro. Hana ʻia ka noiʻi in vitro (Latin: *i ke aniani*, ʻo ia hoʻi i ka ipu aniani) ma waho o ke kino kanaka. ʻAʻole kēia mau huahana he lāʻau lapaʻau, ʻaʻole i ʻae ʻia e ka US Food and Drug Administration (FDA), a ʻaʻole pono e hoʻohana ʻia no ka pale ʻana, mālama, a hoʻōla paha i kekahi maʻi olakino, maʻi, a i ʻole maʻi. Ua pāpā loa ʻia e ke kānāwai ke hoʻokomo i kēia mau huahana i loko o ke kino kanaka a holoholona paha ma kekahi ʻano.